MRI and 18FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from …

…, AF Hottinger, R von Moos, F Caparrotti, K Conen… - Clinical Cancer …, 2021 - AACR
Purpose: To explore a prognostic or predictive role of MRI and O-(2– 18 F-fluoroethyl)-L-tyrosine
( 18 FET) PET parameters for outcome in the randomized multicenter trial ARTE that …

[HTML][HTML] Incidence and predictors of bone metastases (BM) and skeletal-related events (SREs) in small cell lung cancer (SCLC): a Swiss patient cohort

K Conen, R Hagmann, V Hess, A Zippelius… - Journal of …, 2016 - ncbi.nlm.nih.gov
Objectives: Bone metastases (BM) and skeletal-related events (SREs) are frequent complications
in patients with lung cancer. Whereas in non-small-cell lung cancer (NSCLC) incidence…

Vemurafenib-induced radiation recall dermatitis: case report and review of the literature

K Conen, K Mosna-Firlejczyk, C Rochlitz, A Wicki, P Itin… - Dermatology, 2015 - karger.com
The cutaneous effects of BRAF (serine/threonine protein kinase B-raf) inhibitors such as
vemurafenib remain poorly defined. Rash, squamous cell carcinoma, keratoacanthoma and …

Intensity of outpatient physician care in the last year of life: a population-based retrospective descriptive study

…, SR Isenberg, AT Hsu, M Scott, K Conen… - … Open Access Journal, 2021 - cmajopen.ca
Background: For many patients, health care needs increase toward the end of life, but little
is known about the extent of outpatient physician care during that time. The objective of this …

[HTML][HTML] Symptom trajectories of non-cancer patients in the last six months of life: Identifying needs in a population-based home care cohort

K Conen, DM Guthrie, T Stevens, S Winemaker… - Plos one, 2021 - journals.plos.org
Introduction The end-of-life symptom prevalence of non-cancer patients have been described
mostly in hospital and institutional settings. This study aims to describe the average …

Cetuximab in metastatic squamous cell cancer of the skin: a Swiss case series

KL Conen, N Fischer, GFL Hofbauer… - Dermatology, 2014 - karger.com
Background: There is current evidence that non-melanoma skin cancers can be successfully
treated with cetuximab. Objective: To evaluate the use and efficacy of cetuximab (with or …

Complementary and alternative medicine use by glioma patients in Switzerland

G Eisele, U Roelcke, K Conen, F Huber… - Neuro-oncology …, 2019 - academic.oup.com
Background During the course of disease, most glioma patients learn that there is no cure for
their tumor. It is therefore not uncommon for patients or caregivers to seek complementary …

Continuity of physician care over the last year of life for different cause-of-death categories: a retrospective population-based study

…, A Jones, M Scott, AT Hsu, K Conen… - … Open Access Journal, 2022 - cmajopen.ca
Background: The mix of care provided by family physicians, specialists and palliative care
physicians can vary by the illnesses leading to death, which may result in disruptions of …

Inpatient palliative care is associated with the receipt of palliative care in the community after hospital discharge: a retrospective cohort study

…, M Scott, A Hafid, AT Hsu, K Conen… - Journal of Palliative …, 2022 - liebertpub.com
Background: For hospitalized patients with palliative care needs, there is little evidence on
whether postdischarge outcomes differ if inpatient palliative care was delivered by a palliative …

Effects of potassium citrate or potassium chloride in patients with combined glucose intolerance: A placebo-controlled pilot study

K Conen, R Scanni, MT Gombert, HN Hulter… - Journal of Diabetes and …, 2016 - Elsevier
Background Experimental K + depletion reversibly inhibits insulin secretion, while chronic
metabolic acidosis decreases insulin sensitivity. We aimed to investigate the effects of …